Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 8/2016

01-08-2016 | Psychosocial Aspects (S Jaser and KK Hood, Section Editors)

Stress and A1c Among People with Diabetes Across the Lifespan

Authors: Marisa E. Hilliard, Joyce P. Yi-Frazier, Danielle Hessler, Ashley M. Butler, Barbara J. Anderson, Sarah Jaser

Published in: Current Diabetes Reports | Issue 8/2016

Login to get access

Abstract

Stress is known to negatively affect health and is a potentially serious barrier to diabetes-related health outcomes. This paper synthesizes what is known about stress and glycemic control among people with type 1 and type 2 diabetes across the lifespan. Chronic stress—especially in relation to living with diabetes—was most strongly associated with A1c, particularly among subgroups that face disproportionate stress, such as minority groups or adolescents/young adults. Mechanisms of the stress-A1c association include physiological, psychological, behavioral, and environmental links. Understanding the dimensions of stress as they relate to health in diabetes can be of significant clinical importance, and interventions targeting mechanisms that either exacerbate or buffer stress have reported modest improvements in A1c.
Literature
1.
Geiss LS, Wang J, Cheng YJ, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA. 2014;312:1218–26.CrossRefPubMed
2.
American Diabetes Association. Standards of medical care in diabetes—2016. Diabetes Care. 2016;39(1):S1–S112.
3.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRef
4.
Diabetes Control and Complications Trial Study Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44:968–83.CrossRef
5.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
6.
Shichiri M, Kishikawa H, Ohkubo Y, et al. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(Suppl2):B21–9.PubMed
7.
Stark Casagrande S, Fradkin JE, et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013;36:2271–9.CrossRefPubMedPubMedCentral
8.
Miller KM, Foster NC, Beck RW, et al. Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015;38:971–8.CrossRefPubMed
9.
Sherr J, Tamborlane WV, Xing D, Tsalikian E, et al. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function. Diabetes Care. 2012;35:817–20.CrossRefPubMedPubMedCentral
10.
DeSalvo D, Buckingham B. Continuous glucose monitoring: current use and future directions. Curr Diab Rep. 2013;13:657–62.CrossRefPubMed
11.
Johnson SR, Cooper MN, Jones TW, et al. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia. 2013;56:2392–400.CrossRefPubMed
12.
Hood KK, Peterson C, Rohan J, et al. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics. 2009;124(6):e1171–9.CrossRefPubMed
13.
14.
Pouwer F, Kupper N, Adriaanse MC. Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med. 2010;9:112–8.PubMed
15.
16.••
Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabetic Med. 2014;31:764–72. This paper provides one of the first and clearest definitions of the construct of “diabetes distress” (or diabetes-related stress), which is important to differentiate from general stress especially when evaluating associations with glycemic control and in clinical practice.CrossRefPubMedPubMedCentral
17.
18.
19.
Fisher L, Polonsky WH, Hessler DM, et al. Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complications. 2015;29:572–7.CrossRefPubMedPubMedCentral
20.
Fisher L, Hessler DM, Polonsky WH, et al. Prevalence of depression in type 1 diabetes and the problem of over‐diagnosis. Diabetic Med. 2015. epub ahead of print.
21.
Sturt J, Dennick K, Due-Christensen M, et al. The detection and management of diabetes distress in people with type 1 diabetes. Curr Diab Rep. 2015;15:1–14.CrossRef
22.•
Hagger V, Hendrieckx C, Sturt J, et al. Diabetes distress among adolescents with type 1 diabetes: a systematic review. Curr Diab Rep. 2016;16:1–14. This recent review goes into detail about the experiences of diabetes distress in youth with T1D.CrossRef
23.
Fisher L, Mullan JT, Skaff MM, et al. Predicting diabetes distress in patients with type 2 diabetes: a longitudinal study. Diabetic Med. 2009;26:622–7.CrossRefPubMedPubMedCentral
24.
Weinger K, Jacobson AM. Psychosocial and quality of life correlates of glycemic control during intensive treatment of type 1 diabetes. Patient Educ Couns. 2001;42:123–31.CrossRefPubMed
25.
Fisher L, Mullan J, Arean P, et al. Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care. 2010;33:28–8.
26.
27.
Reddy J, Wilhelm K, Campbell L. Putting PAID to diabetes-related distress: the potential utility of the problem areas in diabetes (PAID) scale in patients with diabetes. Psychosomatics. 2013;54:44–51.CrossRefPubMed
28.•
Strandberg RB, Graue M, Wentzel-Larsen T, et al. Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with HbA1c in adult persons with type 1 diabetes. J of Psychosom Res. 2014;77:174–9. This paper compares diabetes-related and general stress constructs in relation to glycemic control, which helps to clarify the relative importance of diabetes-related experiences for research and clinical care.CrossRef
29.
Hessler DM, Fisher L, Mullan JT, et al. Patient age: a neglected factor when considering disease management in adults with type 2 diabetes. Patient Educ Couns. 2011;85:154–9.CrossRefPubMed
30.
Cummings DM, Lutes L, Littlewood K, et al. Regimen-related distress, medication adherence, and glycemic control in rural African American women with type 2 diabetes mellitus. Ann Pharmacother. 2014;48:970–7.CrossRefPubMed
31.
Tsiouli E, Alexopoulos EC, Stefanaki C, et al. Effects of diabetes-related family stress on glycemic control in young patients with type 1 diabetes systematic review. Can Fam Physician. 2013;59:143–9.PubMedPubMedCentral
32.•
Hessler D, Fisher L, Glasgow RE, et al. Reductions in regimen distress are associated with improved management and glycemic control over time. Diabetes Care. 2014;37:617–24. This paper is one of several that demonstrates that diabetes-related stress is a potentially modifiable construct and that changes have the potential to impact self-management and diabetes outcomes in a meaningful way.CrossRefPubMedPubMedCentral
33.
Zagarins SE, Allen NAG, Welch G. Improvement in glycemic control following a diabetes education intervention is associated with change in diabetes distress but not change in depressive symptoms. J Behav Med. 2012;35:299–304.CrossRefPubMed
34.
35.
Lawes T, Franklin V, Farmer G. HbA1c tracking and bio-psychosocial determinants of glycaemic control in children and adolescents with type 1 diabetes: retrospective cohort study and multilevel analysis. Pediatr Diab. 2014;15(5):372–83.CrossRef
36.
Helgeson VS, Escobar O, Siminerio L, et al. Relation of stressful life events to metabolic control among adolescents with diabetes: 5-year longitudinal study. Health Psychol. 2010;29(2):153–9.CrossRefPubMedPubMedCentral
37.
Lloyd CE, Dyer PH, Lancashire RJ, et al. Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care. 1999;22(8):1278–83.CrossRefPubMed
38.
Stenstrom U, Wikby A, Hornqvist JO, et al. Recent life events, gender differences, and the control of insulin-dependent diabetes mellitus. A 2-year follow-up study. Gen Hosp Psychiatr. 1995;17(6):433–9.CrossRef
39.•
Walders-Abramson N, Venditti EM, Ievers-Landis CE, et al. Relationships among stressful life events and physiological markers, treatment adherence, and psychosocial functioning among youth with type 2 diabetes. J Peds. 2014;165(3):504–508 e501. This study from the TODAY Trial is one of the few examinations of stress in the vulnerable population of youth with type 2 diabetes.CrossRef
40.
Goldston DB, Kovacs M, Obrosky DS. A longitudinal study of life events and metabolic control among youths with insulin-dependent diabetes mellitus. Health Psychol. 1995;14:409–14.CrossRefPubMed
41.
Griffith LS, Field BJ, Lustman PJ. Life stress and social support in diabetes: association with glycemic control. Int J of Psychiat in Med. 1990;20:365–72.CrossRef
42.
Kaur G, Tee GH, Ariaratnam S, et al. Depression, anxiety and stress symptoms among diabetics in Malaysia: a cross sectional study in an urban primary care setting. BMC Fam Pract. 2013;14:1.CrossRef
43.
Laraia BA, Karter AJ, Warton EM, et al. Place matters: neighborhood deprivation and cardiometabolic risk factors in the Diabetes Study of Northern California (DISTANCE). Soc Sci Med. 2012;74:1082–90.CrossRefPubMedPubMedCentral
44.
Piette JD, Bibbins-Domingo K, Schillinger D. Health care discrimination, processes of care, and diabetes patients’ health status. Patient Educ Couns. 2006;60:41–8.CrossRefPubMed
45.
Wagner JA, Tennen H, Finan PH, et al. Self‐reported racial discrimination and endothelial reactivity to acute stress in women. Stress Health. 2013;29:214–21.CrossRefPubMed
46.•
Wagner JA, Tennen H, Feinn R, et al. Racial discrimination and metabolic control in women with type 2 diabetes. Ethn Dis. 2015;23:421–7. This paper addresses the important role of stress from perceived racial discrimination and its associations with health outcomes, highlighting the need for more research in this understudied area.
47.
Hilliard ME, Harris MA, Weissberg-Benchell J. Diabetes resilience: a model of risk and protection in type 1 diabetes. Curr Diab Rep. 2012;12:739–48.CrossRefPubMed
48.
Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav R. 2010;35:2–16.CrossRef
49.
Glei DA, Goldman N, Chuang YL, et al. Do chronic stressors lead to physiological dysregulation? Testing the theory of allostatic load. Psychosom Med. 2007;69:769–76.CrossRefPubMed
50.
Abelson JL, Khan S, Liberzon I, et al. Effects of perceived control and cognitive coping on endocrine stress responses to pharmacological activation. Biol Psychiatry. 2008;64:701–7.CrossRefPubMedPubMedCentral
51.
Truninger R, Uthoff H, Capraro J, et al. Glucose control during a driving training in patients with type 1 and type 2 diabetes mellitus—a randomised, controlled trial. Exp Clin Endocr Diab. 2013;121:420–4.CrossRef
52.
Wiesli P, Krayenbühl PA, Kerwer O, et al. Maintenance of glucose control in patients with type 1 diabetes during acute mental stress by riding high-speed rollercoasters. Diabetes Care. 2007;30:1599–601.CrossRefPubMed
53.
Wiesli P, Schmid C, Kerwer O, et al. Acute psychological stress affects glucose concentrations in patients with type 1 diabetes following food intake but not in the fasting state. Diabetes Care. 2005;28:1910–5.CrossRefPubMed
54.
Phan-Hug F, Thurneysen E, Theintz G, et al. Impact of videogame playing on glucose metabolism in children with type 1 diabetes. Pediatr Diabetes. 2011;12:713–7.CrossRefPubMed
55.
Cryer PE. Hypoglycemia in type 1 diabetes mellitus. Enodocrinol Metab Clin N Am. 2010;39:641–54.CrossRef
56.
Cesana G, Panza G, Ferrario M, et al. Can glycosylated hemoglobin be a job stress parameter? J Occup Environ Med. 1985;27:357–60.CrossRef
57.
Xu W, Hang J, Gao W, et al. Association between job stress and newly detected combined dyslipidemia among Chinese workers: findings from the SHISO study. J Occup Health. 2011;53:334–42.CrossRefPubMed
58.
Cutrona CE, Abraham WT, Russell DW, et al. Financial strain, inflammatory factors, and haemoglobin A1c levels in African American women. Brit J of Health Psychol. 2015;20:662–79.CrossRef
59.
Baucom KJ, Queen TL, Wiebe DJ, et al. Depressive symptoms, daily stress, and adherence in late adolescents with type 1 diabetes. Health Psychol. 2015;34:522–30.CrossRefPubMedPubMedCentral
60.
Gonzalez JS, Shreck E, Psaros C, et al. Distress and type 2 diabetes-treatment adherence: a mediating role for perceived control. Health Psychol. 2015;34:505–13.CrossRefPubMed
61.
Tran V, Wiebe DJ, Fortenberry KT, et al. Benefit finding, affective reactions to diabetes stress, and diabetes management among early adolescents. Health Psychol. 2011;30:212–9.CrossRefPubMedPubMedCentral
62.
Yi JP, Vitaliano PP, Smith RE, et al. The role of resilience on psychological adjustment and physical health in patients with diabetes. Brit J of Health Psychol. 2008;13:311–25.CrossRef
63.
Perfect MM, Elkins GR, Lyle‐Lahroud T, et al. Stress and quality of sleep among individuals diagnosed with diabetes. Stress Health. 2010;26:61–74.CrossRef
64.
Knutson KL, Van Cauter E, Zee P, et al. Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes the coronary artery risk development in young adults (CARDIA) sleep study. Diabetes Care. 2011;34:1171–6.CrossRefPubMedPubMedCentral
65.
Barone MT, Menna-Barreto L. Diabetes and sleep: a complex cause-and-effect relationship. Diabetes Res Clin Pract. 2011;91:129–37.CrossRefPubMed
66.
Hilliard ME, Holmes CS, Chen R, et al. Disentangling the roles of parental monitoring and family conflict in adolescents’ type 1 diabetes self-care. Health Psychol. 2013;32:388–96.CrossRefPubMed
67.
Davidson M, Penney EA, Muller B, et al. Stressors and self-care challenges faced by adolescents living with type 1 diabetes. Applied Nursing Research. 2004;17:72–80.CrossRefPubMed
68.
Berlin KS, Rabideau EM, Hains AA. Empirically derived patterns of perceived stress among youth with type 1 diabetes and relationships to metabolic control. J Pediatr Psychol. 2012;37:990–8.CrossRefPubMed
69.
Jaser SS, Grey M. A pilot study of observed parenting and adjustment in adolescents with type 1 diabetes and their mothers. J Pediatr Psychol. 2010;35:738–47.CrossRefPubMed
70.
Rintala TM, Jaatinen P, Paavilainen E, et al. Interrelation between adult persons with diabetes and their family a systematic review of the literature. J Fam Nurs. 2013;19:3–28.CrossRefPubMed
71.
Mayberry LS, Osborn CY. Family support, medication adherence, and glycemic control among adults with type 2 diabetes. Diabetes Care. 2012;35:1239–45.CrossRefPubMedPubMedCentral
72.
Surwit RS, van Tilburg MA, Zucker N, et al. Stress management improves long-term glycemic control in type 2 diabetes. Diabetes care. 2002;25(1):30–4.CrossRefPubMed
73.
Koloverou E, Tentolouris N, Bakoula C, et al. Implementation of a stress management program in outpatients with type 2 diabetes mellitus: a randomized controlled trial. Hormones. 2014;13(4):509–18.PubMed
74.
Tang TS, Funnell MM, Brown MB, et al. Self-management support in “real-world” settings: an empowerment-based intervention. Patient Educ Couns. 2010;79:178–84.CrossRefPubMed
75.
76.
Grey M, Boland EA, Davidson M, et al. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr. 2000;137(1):107–13.CrossRefPubMed
77.
Whittemore R, Jaser SS, Jeon S, et al. An internet coping skills training program for youth with type 1 diabetes: six-month outcomes. Nurs Res. 2012;61:395–404.CrossRefPubMedPubMedCentral
78.
Laffel LMB, Vangsness L, Connell A, et al. Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr. 2003;142:409–16.CrossRefPubMed
79.
Katz ML, Volkening LK, Butler DA, et al. Family-based psychoeducation and care ambassador intervention to improve glycemic control in youth with type 1 diabetes: a randomized trial. Pediatr Diabetes. 2014;15:142–50.CrossRefPubMed
80.
Sturt J, Dennick K, Hessler D, Hunter B, Oliver J, Fisher L. Effective interventions for reducing diabetes distress: systematic review and meta-analysis. Int Diabetes Nurs. 2015;2:40–55.CrossRef
81.
Wysocki T, Harris MA, Buckloh LM, et al. Randomized trial of behavioral family systems therapy for diabetes: maintenance effects on diabetes outcomes in adolescents. Diabetes Care. 2007;30:555–60.CrossRefPubMed
82.
Van Houtum L, Rijken M, Heijmans M, Gorenewegen P. Patient-perceived self-management tasks and support needs of people with chronic illness: generic or disease specific? Ann Behav Med. 2015;49:221–9.CrossRefPubMed
83.
Rosenberg AR, Yi-Frazier JP, Eaton JP, et al. Promoting resilience in stress management: a pilot study of a novel resilience-promoting intervention for adolescents and young adults with serious illness. J Pediatr Psychol. 2015;40:992–9.CrossRefPubMed
84.
Fisher L, Hessler D, Masharani U, Strycker L. Impact of baseline patient characteristics on interventions to reduce diabetes distress: the role of personal conscientiousness and diabetes self-efficacy. Diabet Med. 2014;31:739–46.CrossRefPubMedPubMedCentral
85.
Mochari-Greenberger H, Lee V, Luka A, Peters A, Pande RL. A tele-behavioral health intervention to reduce depression, anxiety, and stress and improve diabetes self-management. Telemedicine e-Health 2016, ahead of print: doi:10.​1089/​tmj.​2015.​0231
86.
Herman WH, Cohen RM. Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. J Clin Endo Metabol. 2012;97:1067–72.CrossRef
87.
Willi SM, Miller KM, DiMeglio LA, et al. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics. 2015;135:424–34.CrossRefPubMedPubMedCentral
88.
Naranjo D, Schwartz DD, Delamater A. Diabetes in ethnically diverse youth: disparate burden and intervention approaches. Curr Diab Rep. 2015;11:251–60.CrossRef
Metadata
Title
Stress and A1c Among People with Diabetes Across the Lifespan
Authors
Marisa E. Hilliard
Joyce P. Yi-Frazier
Danielle Hessler
Ashley M. Butler
Barbara J. Anderson
Sarah Jaser
Publication date
01-08-2016
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 8/2016
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-016-0761-3

Other articles of this Issue 8/2016

Current Diabetes Reports 8/2016 Go to the issue

Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)

An Integrative Analysis of the Effect of Lifestyle and Pharmacological Interventions on Glucose Metabolism in the Prevention and Treatment of Youth-Onset Type 2 Diabetes

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?

Microvascular Complications—Neuropathy (R Pop-Busui, Section Editor)

Targeting the Diabetic Chaperome to Improve Peripheral Neuropathy

Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor)

Management of Type 1 Diabetes in Pregnancy

Immunology and Transplantation (L Piemonti and V Sordi, Section Editors)

Follicular Helper T Cells in Autoimmunity

Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor)

Co-Managing Patients with Type 1 Diabetes and Cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits